Vitamin D Supplement Study for Adolescents
VIP
V.I.P. Feasibility Study (Vitamin D Intake Project)
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 22, 2009
CompletedFirst Posted
Study publicly available on registry
May 28, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedOctober 17, 2011
October 1, 2011
28 days
May 22, 2009
October 14, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma 25-OH D level
3-4 months from baseline to post-testing
Secondary Outcomes (1)
Blood pressure
3-4 months from baseline to post-testing
Study Arms (2)
Daily 2000 IU vitamin D supplement
EXPERIMENTALDaily Vitamin D supplement 400 IU
ACTIVE COMPARATORInterventions
2000 IU vitamin D3 supplement to be taken once daily over 4 months
400 IU Vitamin D3 supplement to be taken daily over 4 months
Eligibility Criteria
You may qualify if:
- Healthy African American Adolescents
You may not qualify if:
- Hypertension
- Pregnancy
- Medications that affect study outcome measures
- Use of other vitamin and/or mineral supplement or herbal supplements
- Individuals of other races
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Georgia Prevention Institute at Medical College of Georgia
Augusta, Georgia, 30912, United States
Related Publications (1)
Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010 Oct;95(10):4584-91. doi: 10.1210/jc.2010-0606. Epub 2010 Jul 21.
PMID: 20660028DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanbin Dong, MD, PhD
Augusta University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2009
First Posted
May 28, 2009
Study Start
February 1, 2009
Primary Completion
March 1, 2009
Study Completion
June 1, 2009
Last Updated
October 17, 2011
Record last verified: 2011-10